Veterinary Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Veterinary Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Veterinary Vaccines Market size is estimated at USD 9.39 billion in 2024, and is expected to reach USD 14.27 billion by 2029, at a CAGR of 8.72% during the forecast period (2024-2029).

An increase in pet adoption in recent years worldwide is expected to boost the demand for companion animal vaccines during the forecast period. For instance, according to data updated by the European Pet Food Industry Federation (FEDIAF), in July 2023, the dog population in the region was over 66.8 million, while the cat population was over 77.9 million. Moreover, according to the same source, in Poland, over 49% of the households owned at least one dog, and over 40% owned a cat in 2023. Such a high rate of pet adoption in the country has increased the focus on the healthcare of animals, thus increasing the demand for appropriate pet vaccines, which is expected to boost market growth.

Additionally, the rising burden of zoonotic diseases is expected to propel the demand for animal vaccines, thereby boosting market growth during the forecast period. For instance, the increasing number of cases of rabies is one of the major factors expected to drive the market's growth over the forecast period. For instance, as per the April 2024 update by the World Health Organization, Oecusse Municipality reported 95 dog exposures, with 10 dogs testing positive for rabies through rapid diagnostic tests in April 2024; among the 95 exposures, seven individuals were bitten by dogs confirmed to have rabies.

The strategic initiatives by governments worldwide for the vaccination of animals are expected to propel market growth. For instance, in June 2022, Indonesia launched a nationwide livestock vaccination program as the number of cattle infected with foot and mouth disease surged to more than 151 thousand. These initiatives create opportunities for market players to develop innovative and effective veterinary vaccines, which is expected to propel market growth.

Therefore, owing to factors such as the high burden of zoonotic diseases, rising pet adoption and vaccination programs, and launches by market players, the market studied is anticipated to witness growth during the forecast period. However, the high storage costs for vaccines and the shortage of veterinarians and skilled farm workers are estimated to restrain market growth.

Veterinary Vaccines Market Trends

The Canine Vaccines Segment is Expected to Hold a Significant Market Share Over the Forecast Period

The demand for canine vaccines is expected to increase rapidly because of the increasing number of pet dogs globally and the rising launches of canine vaccines by market players during the forecast period.

An article published in Acta Scientific Veterinary Sciences in March 2022 stated that India had approximately 6.2 crore community dogs, and it was estimated that the population of pet dogs is likely to reach around 31 million by the end of 2023. In spite of India's huge dog population, awareness regarding the zoonoses transmissible from dogs to humans is highly lacking. Additionally, India's climate is particularly favorable for a wide range of zoonotic diseases, and for the majority of them, canines, including community and companion dogs, serve as reservoir hosts. The large canine population worldwide and the zoonotic diseases associated with them are expected to propel the canine vaccine development and launches during the forecast period.

The activities of market players for the launches, approvals, and partnerships to expand vaccines are expected to boost the segment's growth over the forecast period. For instance, in March 2022, Alv B AS announced the new developments in its feline and canine vaccine, Alvacan. This product line of therapeutic cancer vaccines combines the best of classical cellular immunotherapy with recombinant DNA/RNA technology.

Additionally, in September 2022, the Ministry of Animal Husbandry and Dairy Development announced all stray dogs would be vaccinated, and steps had been initiated to identify hotspots of dog bites. In April 2022, Gujarat-based Cadila Pharmaceuticals launched one of the world's first three-dose anti-rabies vaccines, ThRabis. Therefore, the rising launches of canine vaccines are anticipated to augment the segment's growth during the forecast period.

North America is Expected to Hold a Significant Market Share Over The Forecast Period

The growing pet population and an increase in spending on pet care are fueling market growth. For instance, according to a report published by Forbes Advisor in January 2024, 66% of US households, which was 86.9 million homes, owned a pet. Similarly, according to data from the Canadian Animal Health Institute (CAHI) in September 2022, it was estimated that more than half of Canadian households (60%) owned at least one dog or cat in 2022. The data also detailed that the dog population increased to 7.9 million, and the cat population increased to 8.5 million in 2022. The rising number of pets in the region is expected to create opportunities for the development and availability of advanced veterinary vaccines for the treatment of animals, which is anticipated to fuel market growth over the forecast period.

Additionally, strategic initiatives by market players are expected to propel the market growth in the region during the forecast period. For instance, in September 2022, Merck Animal Health donated more than 5 million doses of its NOBIVAC rabies vaccine to help eliminate canine-mediated rabies.

In May 2022, Ceva Santé Animale (Ceva) acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies Inc. With this acquisition, Ceva will expand its presence in North America.

Therefore, owing to the abovementioned factors, such as the rising pet insurance and spending on animal healthcare, as well as product approvals and launches by market players, the market studied is anticipated to grow in North America.

Veterinary Vaccines Industry Overview

The veterinary vaccines market is semi-consolidated and consists of several major players. Most of these major players enjoy a global presence and face intense competition in emerging economies. Emerging countries are becoming hotspots for significant competition due to the rapidly expanding market, fueled by rising concerns over food safety and the increasing adoption of companion animals. Some market players are Zoetis Inc., Merck & Co. Inc., Virbac, Boehringer Ingelheim International GmbH, Elanco Animal Health, HIPRA, Ceva Sante Animale, and Phibro Animal Health Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support